Copy Number Variations and Cognitive Phenotypes in Unselected Populations

Abstract

The association of copy number variations (CNVs), differing numbers of copies of genetic sequence at locations in the genome, with phenotypes such as intellectual disability has been almost exclusively evaluated using clinically ascertained cohorts. The contribution of these genetic variants to cognitive phenotypes in the general population remains unclear.OBJECTIVE To investigate the clinical features conferred by CNVs associated with known syndromes in adult carriers without clinical preselection and to assess the genome-wide consequences of rare CNVs (frequency Յ0.05%; size Ն250 kilobase pairs [kb]) on carriers' educational attainment and intellectual disability prevalence in the general population. DESIGN, SETTING, AND PARTICIPANTSThe population biobank of Estonia contains 52 000 participants enrolled from 2002 through 2010. General practitioners examined participants and filled out a questionnaire of health-and lifestyle-related questions, as well as reported diagnoses. Copy number variant analysis was conducted on a random sample of 7877 individuals and genotype-phenotype associations with education and disease traits were evaluated. Our results were replicated on a high-functioning group of 993 Estonians and 3 geographically distinct populations in the United Kingdom, the United States, and Italy. MAIN OUTCOMES AND MEASURESPhenotypes of genomic disorders in the general population, prevalence of autosomal CNVs, and association of these variants with educational attainment (from less than primary school through scientific degree) and prevalence of intellectual disability. RESULTSOf the 7877 in the Estonian cohort, we identified 56 carriers of CNVs associated with known syndromes. Their phenotypes, including cognitive and psychiatric problems, epilepsy, neuropathies, obesity, and congenital malformations are similar to those described for carriers of identical rearrangements ascertained in clinical cohorts. A genome-wide evaluation of rare autosomal CNVs (frequency, Յ0.05%; Ն250 kb) identified 831 carriers (10.5%) of the screened general population. Eleven of 216 (5.1%) carriers of a deletion of at least 250 kb (odds ratio [OR], 3.16; 95% CI, 1.51-5.98; P = 1.5e-03) and 6 of 102 (5.9%) carriers of a duplication of at least 1 Mb (OR, 3.67; 95% CI, 1.29-8.54; P = .008) had an intellectual disability compared with 114 of 6819 (1.7%) in the Estonian cohort. The mean education attainment was 3.81 (P = 1.06e-04) among 248 (Ն250 kb) deletion carriers and 3.69 (P = 5.024e-05) among 115 duplication carriers (Ն1 Mb). Of the deletion carriers, 33.5% did not graduate from high school (OR, 1.48; 95% CI, 1.12-1.95; P = .005) and 39.1% of duplication carriers did not graduate high school (OR, 1.89; 95% CI, 1.27-2.8; P = 1.6e-03). Evidence for an association between rare CNVs and lower educational attainment was supported by analyses of cohorts of adults from Italy and the United States and adolescents from the United Kingdom.CONCLUSIONS AND RELEVANCE Known pathogenic CNVs in unselected, but assumed to be healthy, adult popu...

Whole genome sequencing resource identifies 18 new candidate genes for autism spectrum disorder

“…Only the differences in Vineland Adaptive Behavior Score (FDR=0.04) and IQ Full Scale Standard Score (FDR=5×10 −4 ) were significant after multiple testing corrections using Benjamini Hochberg approach. Consistent with the previous studies 41, 42 , we found that individuals with pathogenic CNVs have significantly lower IQ (p=2×10 −3 , −8.5, 95%CI: −16 to −3) (Figure 5a). Similarly, individuals with mutations in ASD-risk genes also have a trend of lower IQ (p=0.02, −11, 95%CI: −15 to −1.6×10 −6 ).…”

The Cognitive and Behavioral Phenotypes of Individuals with CHRNA7 Duplications

“…It is important to consider that the definition of “control” populations may vary among studies. It has been shown that CNVs may have negative effects in the general population, including cognitive impairments and other neuropsychiatric features, however they may not result in clinical attention (Männik et al, 2015; Stefansson et al, 2014). This may contribute to “control” populations having potential for unreported phenotypes, such as ADHD, mood disorders, borderline IQ, and other cognitive or behavioral phenotypes that may not be addressed clinically.…”

16p11.2 deletion and duplication: Characterizing neurologic phenotypes in a large clinically ascertained cohort

“…Though the motor delays or impairments can be mild [Shinawi et al, ], our identification of agility abnormalities in 29% of adult deletion carriers and 19% of adult duplication carriers and high prevalence of agility abnormalities even amongst non‐proband familial carriers in each CNV group (33% deletions, 16% duplications) suggests the possibility that motor impairments could potentially persist after perceived resolution of delays and/or that more subtle motor impairments occur even in those who do not report functional motor impairments. “Sub‐clinical” motor impairments of this nature parallel the unrecognized cognitive sequelae recently found in unselected, presumed “healthy” adult populations with 16p11.2 CNVs [Stefansson et al, ; Männik et al, ].…”